文献速递角膜与眼表疾病

南印度微孢子虫性角结膜炎的临床与人口学研究:一项为期3年的研究(2013-2015年)

Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015).
PubMed 文献 · Br J Ophthalmol · 2017-02-22

该回顾性病例系列分析了2013年1月至2015年12月南印度涂片阳性微孢子虫性角结膜炎患者的人口学特征、临床表现、治疗结果和眼部发病率。在10655例结膜炎患者中,550例(5.2%)涂片阳性;所有患者接受诊断性角膜清创和0.3%氟康唑滴眼液每日四次治疗,随访的296例中187例(63.1%)完全消退无后遗症,视力预后良好。

要点

  • 在10655例结膜炎患者中,550例(5.2%)微孢子虫涂片阳性,全年均有发病,7月至12月发病率增加。
  • 428例(77.8%)患者无易感危险因素,384例(69.1%)就诊前已接受治疗,最常见为抗生素(285例,49.4%)。
  • 随访的296例中,187例(63.1%)完全消退无后遗症,68例(22.9%)持续浅层点状角膜病变,30例(10.1%)发生上皮下钱币状角膜炎。

核心结论

  • 微孢子虫性角结膜炎在南印度全年流行,其特征性临床体征和简单微生物学检查有助于与腺病毒性角结膜炎鉴别,视力预后良好。

研究设计与样本

  • 回顾性病例系列,纳入2013年1月至2015年12月具有微孢子虫性角结膜炎临床特征且革兰染色涂片阳性的所有患者,分析人口学资料、易感因素、微生物学检查、临床病程和视力结果。

主要发现

  • 在10655例结膜炎患者中,550例(5.2%)微孢子虫涂片阳性;全年均有发病,7月至12月发病率增加;双侧受累27例(4.9%)。
  • 428例(77.8%)无易感危险因素;384例(69.1%)就诊前已接受治疗,最常见为抗生素(285例,49.4%)。
  • 所有患者接受诊断性角膜清创和0.3%氟康唑滴眼液每日四次治疗;随访的296例中,187例(63.1%)完全消退无后遗症,68例(22.9%)持续浅层点状角膜病变,30例(10.1%)发生上皮下钱币状角膜炎。
  • 视力无显著变化255眼(80.7%),提高两行及以上48眼(15.2%),下降两行及以上13眼(4.1%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To study the demographic profile, clinical features, treatment outcome and ocular morbidity of smear-positive microsporidial keratoconjunctivitis. METHODS: Retrospective case series of all patients with clinical features of microsporidial keratoconjunctivitis and who were smear positive for the same on Gram stain from January 2013 to December 2015. Demographic data, predisposing factors, microbiological investigations, clinical course and visual outcome were analysed. RESULTS: Of the 10 655 patients with conjunctivitis, 550 (5.2%) patients were positive for microsporidia on Gram stain during this time period. The disease was prevalent throughout the year with an increased incidence from July to December. Bilateral involvement was seen in 27 (4.9%) patients. There was no predisposing risk factor in 428 (77.8%) patients. 384 (69.1%) patients had received prior treatment before presentation to us with the most common drug being antibiotic in 285 (49.4%) patients. All the patients underwent diagnostic corneal debridement and received topical 0.3% fluconazole eye drops four times a day. Of the 296 patients who followed-up, 187 (63.1%) patients had complete resolution without sequelae. 68 (22.9%) had persistent superficial punctate keratopathy, 30 (10.1%) developed subepithelial nummular keratitis. No significant change in visual acuity was seen in 255 (80.7%) eyes, two or more line improvement was seen in 48 (15.2%) eyes, while two or more line worsening was seen in 13 (4.1%) eyes. CONCLUSIONS: Microsporidial keratoconjunctivitis is prevalent in South India throughout the year. The characteristic clinical signs and simple microbiological investigation help us to differentiate it from adenoviral keratoconjunctivitis. The visual prognosis is good.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Agashe R, Radhakrishnan N, Pradhan S, et al. Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015). Br J Ophthalmol. 2017. PMID: 28228409. doi:10.1136/bjophthalmol-2016-309845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。